| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shao Wei-Ming | EVP & General Counsel | C/O STRATEGY INC, 1850 TOWERS CRESCENT PLAZA, TYSONS CORNER | /s/ Allein Sabel, Attorney-in-Fact | 2025-10-09 | 0001663488 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MSTR | Class A Common Stock | Options Exercise | $1.21M | +30K | +235.74% | $40.46 | 42.7K | Oct 7, 2025 | Direct | |
| transaction | MSTR | Class A Common Stock | Sale | -$2.21M | -6.2K | -14.51% | $356.05 | 36.5K | Oct 7, 2025 | Direct | F1 |
| transaction | MSTR | Class A Common Stock | Sale | -$3.69M | -10.3K | -28.27% | $357.14 | 26.2K | Oct 7, 2025 | Direct | F2 |
| transaction | MSTR | Class A Common Stock | Sale | -$4.18M | -11.7K | -44.58% | $358.05 | 14.5K | Oct 7, 2025 | Direct | F3 |
| transaction | MSTR | Class A Common Stock | Sale | -$644K | -1.8K | -12.37% | $358.82 | 12.7K | Oct 7, 2025 | Direct | F4 |
| holding | MSTR | Series A Perpetual Strife Preferred Stock | 500 | Oct 7, 2025 | Direct | ||||||
| holding | MSTR | Series A Perpetual Stretch Preferred Stock | 15K | Oct 7, 2025 | Direct | ||||||
| holding | MSTR | Series A Perpetual Stride Preferred Stock | 3.53K | Oct 7, 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MSTR | Employee Stock Option (Right to buy) | Options Exercise | $0 | -30K | -23.24% | $0.00 | 99.1K | Oct 7, 2025 | Class A Common Stock | 30K | $40.46 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.48 to $356.47, inclusive. The reporting person undertakes to provide to Strategy Inc ("Strategy"), any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.63 to $357.625, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.64 to $358.60, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. |
| F4 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.68 to $359.20, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. |
| F5 | Of the 30,000 shares exercised on October 7, 2025 pursuant to this option, 29,100 shares vested on February 17, 2024 and 900 shares vested on February 17, 2025. Of the remaining 99,100 shares subject to this option, 49,100 shares vested on February 17, 2025 and 50,000 shares are scheduled to vest on February 17, 2026. |